` NOTV (Inotiv Inc) vs S&P 500 Comparison - Alpha Spread

NOTV
vs
S&P 500

Over the past 12 months, NOTV has underperformed S&P 500, delivering a return of +14% compared to the S&P 500's +18% growth.

Stocks Performance
NOTV vs S&P 500

Loading
NOTV
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
NOTV vs S&P 500

Loading
NOTV
S&P 500
Difference
www.alphaspread.com

Performance By Year
NOTV vs S&P 500

Loading
NOTV
S&P 500
Add Stock

Competitors Performance
Inotiv Inc vs Peers

S&P 500
NOTV
0KHE
TMO
DHR
207940
Add Stock

Inotiv Inc
Glance View

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company is headquartered in West Lafayette, Indiana and currently employs 541 full-time employees. The firm focuses on providing drug developers with scientific research and analytical instrumentation. The firm operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.

NOTV Intrinsic Value
18.28 USD
Undervaluation 88%
Intrinsic Value
Price
Back to Top